Fenyvesi Ferenc

1.

Révész, R., Mengenli, A. D., Dossi, E., Alsheikh, R., Nemes, D., Ujhelyi, Z., Pető, Á., Rusznyák, Á., Sipos, É., Gyöngyösi, A., Lekli, I., Bácskay, I., Fenyvesi, F., Haimhoffer, Á.: Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol.
Pharmaceutics. 18 (2), 1-18, (article identifier: 247), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

2.

Takács, P., Rátonyi, D., Kozma, B., Kunkli, A., Fenyvesi, F., Larson, K., Sipos, A. G., Kozma, B.: Development and bioavailability testing of an estetrol and estetrol-zinc-containing vaginal hydrogel: a novel hydroxyethyl cellulose and hydroxypropyl-β-cyclodextrin-based formulation.
Menopause. [Epub ahead of print], 2026.

doi DEA

Journal metrics:

Q1 Obstetrics and Gynecology (2025)

3.

Pócsi, M., Balla, G. J., Fenyvesi, F., Rusznyák, Á., Fejes, Z., Balogh, I., Macek, J. M., Amaral, M. D., Nagy, B. J.: Investigation of HE4 expression concerning epithelial-mesenchymal transition (EMT) in cystic fibrosis epithelial cells.
Journal of Cystic Fibrosis [Epub ahead of print], 2026.

doi DEA Scopus

Journal metrics:

D1 Pediatrics, Perinatology and Child Health (2025)

D1 Pulmonary and Respiratory Medicine (2025)

4.

Fenyvesi, F., Klusóczki, Á., Rusznyák, Á., Zsebik, B., Bácskay, I., Váradi, J.: Cyclodextrin-Based Delivery Systems for Flavonoids: Mechanisms, Advances, Formulation, and Application Opportunities.
Antioxidants. 14 (8), 998-, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

Q1 Clinical Biochemistry

D1 Food Science

Q1 Molecular Biology

Q1 Physiology

5.

Dienes, R. A., Komor, L. A., Péli-Szabó, J., Berzi, A., Emri, M., Szikra, D. P., Fekete, A., Opposits, G., Jószai, I., Kertész, I., Fenyvesi, F., Trencsényi, G., Hajdu, I., Képes, Z.: Preclinical evaluation of Manganese-52 labelled cyclodextrin: a prostaglandin E2 affine imaging probe.
Eur. J. Pharm. Sci. 215, 1-7, (article identifier: 107344), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

6.

Sass, T., Péli-Szabó, J., Dienes, R. A., Árkosy, P., Opposits, G., Jószai, I., Fekete, A., Fenyvesi, F., Hajdu, I., Trencsényi, G., Képes, Z.: Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives.
CTS-Clin. Transl. Sci. 18 (10), 1-9, (article identifier: 70379), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

Q2 Neuroscience (miscellaneous)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

7.

Gyöngyösi, A., Eskeif, S., Kajtár, R., Fenyvesi, F., Fésüs, A., Herczegh, P., Borbás, A., Bereczki, I., Lekli, I.: The role of H2S in isoproterenol-induced cardiac hypertrophy: a comparative study using slow releaser GYY4137 and a newly synthetized fast releaser BM-112.
Biomed. Pharmacother. 192, 1-13, (article identifier: 118660), 2025.

doi DEA Scopus

Journal metrics:

D1 Medicine (miscellaneous)

D1 Pharmacology

8.

Képes, Z., Péli-Szabó, J., Kálmán-Szabó, I., Sass, T., Esze, R., Opposits, G., Jószai, I., Szikra, D. P., Fenyvesi, F., Hajdu, I., Trencsényi, G.: 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: a Proof-of-concept Preclinical Study.
In Vivo. 38 (6), 2591-2600, 2024.

doi DEA Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Pharmacology

9.

Ciceu, A., Fenyvesi, F., Hermenean, A., Ardelean, S., Dumitra, S., Puticiu, M.: Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: molecular Mechanisms and Nanoparticulate Drug Delivery Systems.
Int. J. Mol. Sci. 25 (17), 1-58, (article identifier: 9346), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

10.

Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, (article identifier: 677), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

11.

Hermenean, A., Dossi, E., Hamilton, A., Trotta, M. C., Russo, M., Lepre, C. C., Sajtos, C., Rusznyák, Á., Váradi, J., Bácskay, I., Budai, I., D'Amico,, M., Fenyvesi, F.: Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin-Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics.
Pharmaceuticals (Basel). 17 (1), 1-20, (article identifier: 107), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

12.

Balta, C., Herman, H., Ciceu, A., Lepre, C. C., Mladin, B., Rosu, M., Oatis, D., Russo, M., Peteu, V. E., Gherghiceanu, M., Fenyvesi, F., Cotoraci, C., Trotta, M. C., D'Amico,, M., Hermenean, A.: Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosis.
Biochem. Pharmacol. 229, 116474,, (article identifier: 116474), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Pharmacology

13.

Takács, P., Kozma, B., Rátonyi, D., Kozma, B., Kiss-Szikszai, A., Fenyvesi, F., Sipos, A. G.: Development and Bioavailability Assessment of an Estriol-Containing Vaginal Hydrogel.
Gels. 10 (12), 1-13, (article identifier: 823), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Bioengineering

Q2 Biomaterials

Q1 Organic Chemistry

Q1 Polymers and Plastics

14.

Váradi, J., Oláh, B., Hosszú, D., Fenyvesi, F., Gálné Remenyik, J., Homoki, J., Nagy, B. J., Fejes, Z., Bácskay, I., Klusóczki, Á.: Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis.
Eur. J. Pharm. Sci. 200, 1-10, (article identifier: 106846), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

15.

Ababneh, H. M., Balogh, E., Csiki, D. M., Lente, G., Fenyvesi, F., Tóth, A., Jeney, V.: High glucose promotes osteogenic differentiation of human lens epithelial cells through hypoxia-inducible factor (HIF) activation.
J. Cell. Physiol. 239 (5), 1-12, (article identifier: 31211), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q1 Clinical Biochemistry

Q1 Physiology

16.

Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A. G., Lisztes, E., Tóth, I. B., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, (article identifier: 1052), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q2 Molecular Biology

17.

Ibrahim, Z., Fenyvesi, F.: The role of KRAS in Macropinocytosis and its implications of Multi-Drug Resistance in Cancer.
DRem. 1 (1), 39-49, 2024.

doi DEA

18.

Gyöngyösi, A., Csáki, N., Pető, Á., Szőke, K., Fenyvesi, F., Bácskay, I., Lekli, I.: BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function.
Int. J. Mol. Sci. 24 (6), 1-13, (article identifier: 5269), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

19.

Gutay-Tóth, Z., Gellén, G., Doan-Xuan, Q. M., Eliason, J. F., Vincze, J., Szente, L., Fenyvesi, F., Goda, K., Vecsernyés, M., Szabó, G., Bacsó, Z.: Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.
Int. J. Mol. Sci. 24 (15), 12335, (article identifier: 12335), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

20.

Trotta, M. C., Herman, H., Ciceu, A., Mladin, B., Rosu, M., Lepre, C. C., Russo, M., Bácskay, I., Fenyvesi, F., Marfella, R., Hermenean, A., Balta, C., D'Amico,, M.: Chrysin-based supramolecular cyclodextrin-calixarene drug delivery system: a novel approach for attenuating cardiac fibrosis in chronic diabetes.
Front. Pharmacol. 14, 1-17, (article identifier: 1332212), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

21.

Klusóczki, Á., Oláh, B., Hosszú, D., Fenyvesi, F., Gálné Remenyik, J., Homoki, J., Gyöngyösi, A., Bácskay, I., Váradi, J.: Effectiveness of Anthocyanin-Rich Sour Cherry Extract on Gliadin-Induced Caco-2 Barrier Damage.
Nutrients. 15 (18), 1-16, (article identifier: 4022), 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Food Science

D1 Nutrition and Dietetics

22.

Demeter, F., Török, P., Kiss, A., Kovásznai-Oláh, R., Máthéné Szigeti, Z., Baksa, V., Kovács, F., Balla, N., Fenyvesi, F., Váradi, J., Borbás, A., Herczeg, M.: First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity.
Int. J. Mol. Sci. 24 (4), 1-20, (article identifier: 3550), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

23.

Rusznyák, Á., Réti-Nagy, K., Váradi, J., Bácskay, I., Vecsernyés, M., Fenyvesi, F.: Hidroxi-propil-béta-ciklodextrin celluláris internalizációjának és lizoszómákra gyakorolt hatásának vizsgálata.
egis. 2 (2), 57-64, 2023.

doi DEA

24.

Képes, Z., Hajdu, I., Fenyvesi, F., Trencsényi, G.: Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era.
Int. J. Pharm. 640, 1-12, (article identifier: 122978), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

25.